Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors

Nanomedicine application in cancer immunotherapy is currently one of the most challenging areas in cancer therapeutic intervention. Innovative solutions have been provided by nanotechnology to deliver cytotoxic agents to the cancer cells partially affecting the healthy cells of the body during the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zulfiqar, Bilal, Mahroo, Amnah, Nasir, Kaenat, Farooq, Rai Khalid, Jalal, Nasir, Rashid, Muhammad Usman, Asghar, Kashif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268369/
https://www.ncbi.nlm.nih.gov/pubmed/28176942
http://dx.doi.org/10.2147/OTT.S119362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268369/
https://www.ncbi.nlm.nih.gov/pubmed/28176942
http://dx.doi.org/10.2147/OTT.S119362

Ejemplares similares